Blog
April 20, 2021
Using Machine Learning to Enhance Precision Oncology
Precision medicine instruments produce incredible amounts of data, sometimes measured in terabytes or even petabytes.
Canexia Health’s Co-Founder and Chief Medical Officer David Hunstman was recently interviewed by OncLive as part of their OncLive On Air Podcast. OncLive is a digital platform that offers resources and information to oncology professionals that they can use to help provide the best patient care.
In this exclusive interview, Dr. Huntsman discusses the elements of precision medicine that have contributed to its growth in oncology, some of the setbacks regarding its integration, and areas of research that have the potential to propel precision medicine to the next tier of scientific discovery and application.
Recent Resources
Press
March 11, 2021
Cancer patients must not become collateral damage in fight against pandemic
If we are to minimize the now well-documented burdens of COVID-19 on cancer patients, governments must support innovations that improve their outcomes and cut through the healthcare roadblocks posed by the pandemic.
Blog
March 2, 2021
Assessing the Real World Accuracy of ctDNA Diagnostics
Canexia Health's Chief Scientific Officer writes about the importance of combining different approaches to obtain correct results for ctDNA diagnostics. While high sensitivity is important, it must be contextualized with other key measurements.